Pink Sheet | What the FDA’s Inspections Q&A Guidance Really Means: It’s Time to Offer Virtual Inspections

Cathy Burgess is quoted on recent guidance by the U.S. Food and Drug Administration that could include virtual inspections of manufacturing sites amid COVID-19 and how the industry should continue urging the FDA to adopt these new approaches.